Apyx Medical Corp Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants
Apyx Medical Corp (APYX) reported Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants of 0 shares for the 3-month period ending 2018-06-30, per its 10-Q filed 2018-08-01.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants · last filed 2018-08-01
- Apyx Medical Corp incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2018-06-30 was 0.00 shares.
- Apyx Medical Corp incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2018-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- Apyx Medical Corp incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2017-09-30 was 0.00 shares.
- Apyx Medical Corp incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2017-06-30 was 0.00 shares.
- Apyx Medical Corp incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2017 was 7.00K shares, a 56.25% decline from fiscal 2016.
- Apyx Medical Corp incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2016 was 16.00K shares, a 42.86% decline from fiscal 2015.
- Apyx Medical Corp incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2015 was 28.00K shares.
- Apyx Medical Corp incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2014 was 0.00 shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 3 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 6 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 9 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 12 month |
|---|---|---|---|---|
| 2018-06-30 | 0.00 shares 10-Q · filed 2018-08-01 | 0.00 shares 10-Q · filed 2018-08-01 | ||
| 2018-03-31 | 0.00 shares 10-Q · filed 2018-05-15 | |||
| 2017-12-31 | 7.00K shares 10-K · filed 2018-03-13 | |||
| 2017-09-30 | 0.00 shares 10-Q · filed 2017-11-03 | 0.00 shares 10-Q · filed 2017-11-03 | ||
| 2017-06-30 | 0.00 shares 10-Q · filed 2018-08-01 | 0.00 shares 10-Q · filed 2018-08-01 | ||
| 2017-03-31 | 27.00K shares 10-Q · filed 2018-05-15 | |||
| 2016-12-31 | 16.00K shares 10-K · filed 2018-03-13 | |||
| 2016-09-30 | 0.00 shares 10-Q · filed 2017-11-03 | 0.00 shares 10-Q · filed 2017-11-03 | ||
| 2016-06-30 | 0.00 shares 10-Q · filed 2017-08-03 | 0.00 shares 10-Q · filed 2017-08-03 | ||
| 2016-03-31 | 0.00 shares 10-Q · filed 2017-05-15 | |||
| 2015-12-31 | 28.00K shares 10-K · filed 2018-03-13 | |||
| 2014-12-31 | 0.00 shares 10-K · filed 2017-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |